Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on October 24, 2025

October 24, 2025

Incontinence Devices Market Projected to Hit US$ 10.92 billion by 2033, Industry Developemts, Future Growth

EIN Presswire

October 24, 2025

Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details

GlobeNewswire

October 24, 2025

Cosmetic CDMO Market To Hit US$35.79 Billion By 2033, Industry Size, Future Growth

EIN Presswire

October 24, 2025

Pennant Announces Third Quarter 2025 Earnings Release and Call

GlobeNewswire

October 24, 2025

Enzon and Viskase Announce Amendment to Merger Agreement

GlobeNewswire

October 24, 2025

60 Iconic Canadian Landmarks to Light Up Blue for World Occupational Therapy Day

GlobeNewswire

October 24, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

October 24, 2025

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

GlobeNewswire

October 24, 2025

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

GlobeNewswire

October 24, 2025

BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week

GlobeNewswire

October 24, 2025

Arvinas Presents Preclinical Data for ARV-806 Demonstrating Robust and Differentiated Activity in Models of KRAS G12D-mutated Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

Picard Issues Statement on Intraday Stock Price

GlobeNewswire

October 24, 2025

Chronic Obstructive Pulmonary Disease Drugs Market to Reach USD 30.13 Billion by 2032

EIN Presswire

October 24, 2025

Theriva Biologics Provides Response to Unusual Market Action

GlobeNewswire

$Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia$

October 24, 2025

Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

GlobeNewswire

October 24, 2025

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference

GlobeNewswire

October 24, 2025

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference

GlobeNewswire

October 24, 2025

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors

GlobeNewswire